NIH study finds tecovirimat was safe but did not improve mpox resolution or pain: Bethesda, Maryland Thursday, December 12, 2024, 15:00 Hrs [IST] The antiviral drug tecovirimat di ...

IC-MPGN market growth driven by rising prevalence, emerging premium-priced therapies, and off-label treatments addressing chronic immune-related kidney damage in adult populations.Dublin, Dec. 12, ...